Kardigan (KARD) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $13.03, -6.12% vs the prior close of $13.88.
- Volume 717.61K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
KARD slides 6.1% to $13.03. Closed at $13.03, -6.12% vs the prior close of $13.88. Day range $12.76–$14.51, opened at $13.95.
KARD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — KARD slides 6.1% to $13.03
- Closed at $13.03, -6.12% vs the prior close of $13.88. Day range $12.76–$14.51, opened at $13.95.
- Volume was 717.61K shares, 1.2x its 50-day average of 585.78K.
- Price is -27.2% vs its 50-day average ($17.89).
- 52-week range $12.23–$27.00; today's close sits at 5% of that range, 51.7% below the 52-week high.
Oct 15, 2026 — KARD rises 2.7% to $13.88
- Closed at $13.88, +2.66% vs the prior close of $13.52. Day range $13.13–$14.13, opened at $13.80.
- Volume was 660.90K shares, 1.1x its 50-day average of 575.98K.
- Price is -23.1% vs its 50-day average ($18.04).
- 52-week range $12.23–$27.00; today's close sits at 11% of that range, 48.6% below the 52-week high.
Oct 14, 2026 — KARD jumps 4.2% to $13.52
- Closed at $13.52, +4.24% vs the prior close of $12.97. Day range $12.34–$13.61, opened at $12.53.
- Volume was 826.70K shares, 1.5x its 50-day average of 562.19K.
- Price is -25.6% vs its 50-day average ($18.17).
- 52-week range $12.23–$27.00; today's close sits at 9% of that range, 49.9% below the 52-week high.
Oct 13, 2026 — KARD slides 9.6% to $12.97, a 3-month low
- Closed at $12.97, -9.62% vs the prior close of $14.35. Day range $12.93–$14.61, opened at $14.36.
- Volume was 392.60K shares, 0.7x its 50-day average of 558.83K.
- Price is -29.1% vs its 50-day average ($18.31).
- 52-week range $12.23–$27.00; today's close sits at 5% of that range, 52.0% below the 52-week high.
Oct 12, 2026 — KARD dips 2.2% to $14.35
- Closed at $14.35, -2.18% vs the prior close of $14.67. Day range $14.21–$15.10, opened at $14.69.
- Volume was 256.80K shares, 0.5x its 50-day average of 559.31K — lighter than usual.
- Price is -22.2% vs its 50-day average ($18.45).
- 52-week range $12.23–$27.00; today's close sits at 14% of that range, 46.9% below the 52-week high.
Oct 9, 2026 — KARD jumps 3.3% to $14.67, 3 up days in a row
- Closed at $14.67, +3.31% vs the prior close of $14.20. Day range $14.13–$15.93, opened at $14.44.
- Volume was 740.20K shares, 1.4x its 50-day average of 547.36K.
- Price is -21.0% vs its 50-day average ($18.57).
- 52-week range $12.23–$27.00; today's close sits at 17% of that range, 45.7% below the 52-week high.
- That makes 3 straight gains.
Oct 8, 2026 — KARD rises 2.7% to $14.20
- Closed at $14.20, +2.68% vs the prior close of $13.83. Day range $13.42–$14.47, opened at $13.60.
- Volume was 511.80K shares, 0.9x its 50-day average of 540.37K.
- Price is -24.0% vs its 50-day average ($18.69).
- 52-week range $12.23–$27.00; today's close sits at 13% of that range, 47.4% below the 52-week high.
Oct 7, 2026 — KARD rises 2.5% to $13.83 on 2.0x normal volume
- Closed at $13.83, +2.52% vs the prior close of $13.49. Day range $12.23–$14.19, opened at $13.34.
- Volume was 1.03M shares, 2.0x its 50-day average of 522.75K — unusually heavy trading.
- Price is -26.4% vs its 50-day average ($18.80).
- 52-week range $12.23–$27.00; today's close sits at 11% of that range, 48.8% below the 52-week high.
Oct 6, 2026 — KARD slides 11.5% to $13.49, a 3-month low on 3.2x normal volume
- Closed at $13.49, -11.48% vs the prior close of $15.24. Day range $12.52–$15.25, opened at $15.25.
- Volume was 1.56M shares, 3.2x its 50-day average of 494.36K — unusually heavy trading.
- Price is -28.8% vs its 50-day average ($18.94).
- 52-week range $12.52–$27.00; today's close sits at 7% of that range, 50.0% below the 52-week high.
Oct 5, 2026 — KARD jumps 3.0% to $15.24
- Closed at $15.24, +3.04% vs the prior close of $14.79. Day range $14.35–$15.40, opened at $14.77.
- Volume was 380.90K shares, 0.8x its 50-day average of 489.89K.
- Price is -20.2% vs its 50-day average ($19.10).
- 52-week range $13.75–$27.00; today's close sits at 11% of that range, 43.6% below the 52-week high.
Oct 2, 2026 — KARD jumps 3.8% to $14.79
- Closed at $14.79, +3.79% vs the prior close of $14.25. Day range $14.15–$15.27, opened at $14.48.
- Volume was 524.40K shares, 1.1x its 50-day average of 483.22K.
- Price is -23.0% vs its 50-day average ($19.21).
- 52-week range $13.75–$27.00; today's close sits at 8% of that range, 45.2% below the 52-week high.
KARD latest news & SEC filings
Every SEC filing by or about KARD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Oct 1, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 1, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$116.24M (prior year -$57.45M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$4.61 (prior year -$4.64) (loss narrowed vs Jun 30, 2025)
Aug 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 29, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 25, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 24, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hrtg Pv, L.P. bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- Hrtg Pv, L.P. bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- Hrtg Gpe, Llc bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- Hrtg Gpe, Llc bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- Kelly Kevin Anthony bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- Kelly Kevin Anthony bought 3,125,000 shares at $16.00 (≈$50.00M) on Jun 22, 2026
- …plus 14 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade KARD
- Last results release: Aug 11, 2026 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 3.74% (largest 11.7%). That is a volatile stock.
- Liquidity: about 666.33K shares (≈$8.68M) trade per day on average.
- 52-week position: $13.03 vs a range of $12.23–$27.00 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 25 open-market buys, 0 sales; latest: Pv, L.P. Hrtg bought 3,125,000 shares on Jun 22, 2026.
- Latest filings: 8-K Sep 30, 2026; 10-Q Aug 11, 2026; 8-K Aug 11, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
KARD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 13.95 | 14.51 | 12.76 | 13.03 | 717.61K |
| Oct 15, 2026 | 13.80 | 14.13 | 13.13 | 13.88 | 660.90K |
| Oct 14, 2026 | 12.53 | 13.61 | 12.34 | 13.52 | 826.70K |
| Oct 13, 2026 | 14.36 | 14.61 | 12.93 | 12.97 | 392.60K |
| Oct 12, 2026 | 14.69 | 15.10 | 14.21 | 14.35 | 256.80K |
| Oct 9, 2026 | 14.44 | 15.93 | 14.13 | 14.67 | 740.20K |
| Oct 8, 2026 | 13.60 | 14.47 | 13.42 | 14.20 | 511.80K |
| Oct 7, 2026 | 13.34 | 14.19 | 12.23 | 13.83 | 1.03M |
| Oct 6, 2026 | 15.25 | 15.25 | 12.52 | 13.49 | 1.56M |
| Oct 5, 2026 | 14.77 | 15.40 | 14.35 | 15.24 | 380.90K |
| Oct 2, 2026 | 14.48 | 15.27 | 14.15 | 14.79 | 524.40K |
| Oct 1, 2026 | 14.65 | 15.13 | 13.94 | 14.25 | 913.90K |
| Sep 30, 2026 | 14.81 | 14.87 | 14.16 | 14.75 | 487.80K |
| Sep 29, 2026 | 14.75 | 15.06 | 14.33 | 14.66 | 493.60K |
| Sep 28, 2026 | 14.59 | 15.25 | 14.59 | 14.78 | 364.90K |
| Sep 25, 2026 | 14.69 | 15.60 | 14.07 | 14.79 | 628.90K |
| Sep 24, 2026 | 14.54 | 14.54 | 13.75 | 14.39 | 862.40K |
| Sep 23, 2026 | 16.50 | 16.50 | 14.24 | 14.52 | 653.80K |
| Sep 22, 2026 | 16.55 | 16.58 | 16.08 | 16.44 | 598.20K |
| Sep 21, 2026 | 16.86 | 18.28 | 16.13 | 16.30 | 724.50K |
About Kardigan
Kardigan (KARD) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2123613.
KARD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Venture Fund Xiii, L.P. Arch | Director | Jun 24, 2026 |
| Venture Partners Xiii, L.P. Arch | Director | Jun 24, 2026 |
| Venture Partners Xiii, Llc Arch | Director | Jun 24, 2026 |
| Paul L Berns | Director | Jun 24, 2026 |
| Kristina Burow | Director | Jun 24, 2026 |
| Keith Crandell | Director | Jun 24, 2026 |
| Joseph Edelman | Director | Jul 13, 2026 |
| Anastasios Gianakakos | President & CEO | Jun 22, 2026 |
| Steven Gillis | Director | Jun 24, 2026 |
| Douglas E. Giordano | Director | Jun 22, 2026 |
| David P Meeker | Director | Jun 22, 2026 |
| Robert Nelsen | Director | Jun 24, 2026 |
| Advisors Llc Perceptive | Director | Jul 13, 2026 |
| Life Sciences Master Fund Ltd Perceptive | Director | Jul 13, 2026 |
| Capital Solutions Holdings Lp Perceptive | Director | Jul 13, 2026 |
| Kimberly J Popovits | Director | Jun 22, 2026 |
| Timothy P Walbert | Director | Jun 22, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jay Edelberg | Chief Medical Officer | Jun 22, 2026 |
| Anastasios Gianakakos | President & CEO | Jun 22, 2026 |
| Brianne Jahn | Chief Financial Officer | Jun 22, 2026 |
| John B Moriarty | Chief Legal Officer | Jun 22, 2026 |
| Andy Pasternak | Chief Strategy Officer | Jun 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Pv, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Pv, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Gpe, Llc Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Gpe, Llc Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Kevin Anthony Kelly | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Kevin Anthony Kelly | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Keith Bryon Johnson | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Keith Bryon Johnson | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Cif 2024, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Cif 2024, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Pv, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Pv, L.P. Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Gpe, Llc Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Gpe, Llc Hrtg | Buy | 3,125,000 | $16.00 |
| Jun 22, 2026 | Kevin Anthony Kelly | Buy | 3,125,000 | $16.00 |
KARD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $721.79M, total liabilities $106.26M, cash $384.00M (as of Jun 30, 2026).
KARD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 11, 2026 | 8-K Item 2.02 (results) | $22.06 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on KARD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.